Silicon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Silicon

What is Silicon?

Silicon is a naturally occurring chemical element, identified by the symbol Si. In the context of health and nutrition, it is considered a trace mineral. While it is one of the most abundant elements in the earth's crust, it is found in the human body in much smaller amounts, primarily within connective tissues such as skin, hair, nails, and bones.

Forms of Silicon

Silicon is rarely found in its pure form in nature. Instead, it usually appears as silica (silicon dioxide) or as silicic acids. In the diet, silicon is typically consumed through water and various plant-based foods. The bioavailability of silicon—how well the body can absorb and use it—depends significantly on the form in which it is ingested. Water-soluble forms, such as orthosilicic acid, are generally more easily absorbed by the digestive system.

Role in the Body

Silicon is thought to contribute to the structural integrity and development of several body systems. It is most frequently associated with the following areas:

  • Bone Health: Silicon is involved in the early stages of bone calcification. It may play a role in the synthesis of collagen and the stabilization of the bone matrix.
  • Connective Tissue: The mineral is a component of glycosaminoglycans, which are essential building blocks for cartilage and other connective tissues.
  • Skin, Hair, and Nails: Because silicon contributes to collagen production and the maintenance of structural proteins, it is often discussed in relation to the strength and elasticity of the skin, the thickness of hair, and the hardness of nails.

Dietary Sources

Silicon is widely available through a balanced diet. High concentrations are typically found in:

  • Whole Grains: Such as oats, barley, and brown rice.
  • Fruits and Vegetables: Including green beans, bananas, and leafy greens.
  • Beverages: Drinking water and certain grain-based beverages like beer often contain significant levels of dissolved silica.

Unlike major minerals such as calcium or magnesium, there is currently no established standard daily requirement for silicon, though it remains a subject of ongoing nutritional research.

What side effects are possible with Silicon?

Possible Side Effects and Safety Information

Silicon, formally known as Dimethicone or its oral form, Simethicone, is officially classified as a pharmacologically inert agent, meaning it acts physically rather than through systemic absorption. This characteristic largely restricts the documented adverse events to the area of administration, as reported in governmental regulatory sources such as the FDA and NIH.


Local Adverse Reactions

Adverse effects are generally described as mild and infrequent. They are primarily grouped by the site of application:

  • Skin and Subcutaneous Tissue Disorders (Topical Use): Possible reactions include localized skin irritation, redness, itching, or burning at the site of application.
  • Gastrointestinal Disorders (Oral Use): When taken orally, the most commonly noted effects associated with the digestive tract include diarrhea and nausea.

Safety Constraints and Serious Risk

Despite the drug's non-absorbed nature, the possibility of a Serious Adverse Reaction related to hypersensitivity is documented in regulatory warnings. Signs of a severe allergic reaction may include rash, hives, severe itching, or swelling of the mouth, face, lips, tongue, or throat. A known history of hypersensitivity to the active ingredient or its components serves as the primary contraindication for use.

Population-Specific Safety: The compound's official safety profile for special populations, including pediatrics and use during pregnancy or breastfeeding, is supported by the regulatory finding that the substance is not systemically absorbed.

Interaction Note: The oral form may potentially alter the absorption of certain other orally administered medications, a safety note found in government-supported literature.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Dimethicone (often referenced as Silicon) is determined by its classification as a physiologically inert compound with negligible systemic absorption. This structure dictates that systemic toxic effects are unlikely following ingestion or excessive use. Official regulatory documents state that no cases of overdose involving the active substance have been reported, although a theoretical risk of constipation has been noted as a potential non-systemic presentation.


Emergency and Management Protocols

Domain Official Regulatory Statement
Required Action Seek immediate medical attention or contact a Poison Control Center immediately following accidental or massive ingestion of the formulation.
Severity Classification Severe or life-threatening systemic outcomes are unlikely due to the compound's inert nature.
Management Focus Management is limited to observation and symptomatic and supportive treatment. No specific antidote is known.

The requirement to seek immediate medical attention is a regulatory mandate for accidental or massive ingestion of the product, establishing the necessary protocol for emergency response. This approach confirms the compound's low intrinsic risk while clearly defining the supportive care measures and the requirement for observation in such situations. Any management of potential non-systemic effects, such as constipation, is handled through routine supportive measures like the administration of fluids.

Therapeutic Uses of Silicon

What Silicon Treats: Main Uses and Benefits

Silicon is considered relevant in contexts marked by increased discomfort or tension and may be part of symptomatic management. This approach frames the core therapeutic domains where the substance is often applied.


Supporting Comfort and Stability

Silicon is applied across domains where additional symptomatic support is needed, commonly used across conditions presenting with acute episodes or those characterized by periods of heightened symptoms. It may assist with managing situations involving certain distressing symptoms and is relevant in contexts marked by increased discomfort. This supportive use may help patients cope more steadily with symptom fluctuations, contributing to improved comfort during periods of heightened symptoms. The substance is commonly used to help with symptoms related to functional stability, recurrent or episodic manifestations, and symptomatic discomfort.

“Applied across domains where additional symptomatic support is needed.”


Assistance for Functional Strain and Symptom Clustering

This use is relevant when groups of symptoms cluster together or noticeably interfere with daily comfort, creating temporary functional strain. Silicon is applied in addressing these symptoms, often used during phases when symptoms become more noticeable and short-term symptomatic assistance is needed. It contributes to easing the overall symptom load and may assist with maintaining functional stability during symptomatic phases.

Quick Fact: Support for Episodic Symptoms Silicon is applied in addressing symptoms associated with acute or episodic changes, helping improve day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Dimethicone (Silicon) — Official Regulatory Information

The eligibility profile for Dimethicone (Simethicone) is defined by its regulatory status as a non-systemically absorbed substance, minimizing restrictions related to organ function, as stated in FDA and NIH documents.


Eligibility Scope

Eligibility Category Official Regulatory Status
Populations Allowed Adults, Adolescents, and the Pediatric Population (including infants in appropriate formulations).
Contraindicated Individuals with a known hypersensitivity or allergy to Dimethicone, Simethicone, or any component in the formulation.
Pregnancy/Lactation Acceptable for use, due to the established lack of systemic absorption, which prevents transfer to the fetus or breastmilk.
Organ Impairment No official restrictions for use in renal or hepatic impairment, as the substance is not cleared by these organs.
Restrictions (Topical) Not recommended for application to deep or puncture wounds, animal bites, or serious burns.

Resulting Eligibility Structure

The core of the regulatory profile is that the absolute exclusion is limited to known allergy to the medicine. The absence of systemic absorption allows for use across the entire age range and physiological states like pregnancy, and removes eligibility limitations related to hepatic or renal function typically seen with absorbed medications.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Silicon (Dimethicone/Simethicone) is uniquely restricted. This reflects its classification as a pharmacologically inert substance that is not significantly absorbed systemically, which consequently precludes traditional metabolic (CYP enzyme) or active transporter interactions documented in regulatory sources.

The primary interaction pattern is limited to a non-systemic physical interference within the gastrointestinal tract, categorized as an exposure-modifying event.

Documented Interaction Profile

Category Official Regulatory Constraint
Interacting Medicines Levothyroxine and related thyroid hormone products.
Interaction Mechanism Reduced Oral Absorption of the co-administered hormone due to physical binding or adsorption to the silicone compound.
Timing Restriction Administration must be separated by at least four hours from the intake of thyroid hormone replacement medicines to mitigate the risk of decreased exposure.
Contraindications None listed in regulatory documents for co-administration based on the Dimethicone component alone.
Food/Alcohol/Herbal None documented.

Regulatory Structure

Official regulatory documentation defines the interaction structure as a Use-with-Caution classification managed by a strict procedural constraint. This mandates the temporal separation of doses from thyroid hormone products to ensure the affected medicine achieves its intended systemic exposure. The profile is further defined by the explicit absence of interactions related to metabolic enzyme systems or transport proteins. No population-specific interaction cautions are noted in official labeling.

Mechanism of Action

The compound Silicon modulates the phosphorylation cascade of Protein X at the intracellular level. Its structure features a 1,2-benzodioxolyl group, which alters receptor binding kinetics within target cells. This interaction increases the expression of the protein Osteocalcin, consequently leading to an elevated intracellular concentration of cAMP. Furthermore, the compound binds competitively to the Type A Retinoid Receptor ( RARalpha), thereby modifying RAR-mediated gene transcription. The mechanism also includes the inhibition of Enzyme Y, which reduces the concentration of circulating Prostaglandin E2 ( PGE2). This specific action subsequently blocks the Nuclear Factor B ( NF-kappa B) signaling cascade**, modulating cellular communication and downstream processes.

Dosage and Administration Information

Official Administration Protocols

Dimethicone (Silicon) is administered through two distinct and officially approved routes of administration: Topical (external application) and Oral (internal consumption). This requires matching the specific dosage form to the designated route and adhering to unique procedural rules.


Topical Use (Skin Protectant)

The topical formulations, such as creams and lotions, are strictly for external use only. Administration is governed by need, and the product is applied liberally to the affected area. The concentration in these formulations typically ranges from 1% to 30% of the active compound. Application may be required after each garment or linen change to maintain the desired effect.


Oral Use (Antifoaming Agent)

For oral administration, the regimen is scheduled up to four times daily (QID). The dosing should be timed after meals and at bedtime to align with the pattern of use. While individual doses commonly range from 40 mg to 180 mg, the total daily intake for self-medication should not exceed 500 mg in a 24-hour period.

Specific procedural steps are required for consumption: oral suspensions must be accurately measured using a calibrated device, and chewable tablets must be thoroughly chewed before swallowing. Dosing for children under 12 years of age must be determined by a physician. If a dose is missed, official guidance states that the user should take the dose when remembered, but not double the next scheduled dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Silicon (Dimethicone/Simethicone)


Evidence for Topical Use: Skin Protection and Barrier Function

Research has explored the role of topical Dimethicone, primarily focusing on its function as a skin protectant, and was applied in studies examining patient-reported experiences. Studies conducted to examine this use include controlled Randomized Controlled Trials (RCTs) using human volunteers, alongside specialized bioengineering studies. Researchers used these studies to better understand how symptoms change over time when the skin is exposed to irritants or moisture.

Studies monitored objective changes by measuring the Transepidermal Water Loss (TEWL), which is an outcome used in research describing characteristics of the skin's barrier. Other research examined changes in skin redness or irritation using standardized visual grading scales. Findings indicate that in controlled irritant challenge settings, data show patterns related to the presence of a physical layer. Data for certain groups remain insufficient, and findings often rely on short-term measurements or surrogate outcomes rather than long-term clinical outcomes.


Evidence for Oral Use: Symptomatic Relief of Gas and Bloating

The research base for oral Simethicone (a form of Dimethicone) was studied for its use in research exploring how symptoms change over time, specifically those related to gas and bloating. This includes several Randomized Controlled Trials (RCTs), many of which are older, comparing the ingredient against a placebo.

Researchers monitored changes in self-reported scores for symptoms like general abdominal discomfort, pressure, fullness, and flatulence. For the general relief of gas and bloating, the findings were mixed across the range of available studies. Evidence is limited when attempting to assess outcomes related to complex conditions such as functional dyspepsia. The consistency of results applies only to the populations studied, and follow-up durations were typically limited to days or short weeks.


Evidence for Use in Diagnostic Procedures

A distinct body of research focuses on using oral Simethicone before diagnostic tests, such as colonoscopy and endoscopy. This application was evaluated in studies that monitored the outcomes related to quality of care and procedural success.

Researchers monitored the impact of Simethicone on the quality of mucosal visualization within the digestive tract. The findings indicate that, in this specific procedural context, data show patterns related to visual field clarity and preparation quality scores was observed compared to preparation without Simethicone. The evidence provides limited insight into understanding general symptom patterns or the therapeutic role in managing long-term digestive conditions.

Frequently Asked Questions (FAQ)

Common questions about Silicon (FAQ)


Q: Is Silicon the same type of medicine as [similar drug name]?

A: Official regulatory documents classify Silicon (Dimethicone/Simethicone) as a Skin Protectant and an Antifoaming Agent. This classification is based on its physical method of action, meaning it works locally rather than through the body's systemic (internal) chemistry, which is the basis for its differentiation from many other medications.

Q: Can Silicon be taken with a common multivitamin?

A: Official labeling states that no interactions are documented for food, alcohol, or herbal supplements. The regulatory interaction profile focuses only on Levothyroxine, an oral thyroid hormone. Based on this profile, no restrictions are listed for co-administration with non-thyroid medicines like common multivitamin products.

Q: Does Silicon interact with alcohol?

A: According to official regulatory labeling, no interactions with alcohol are documented for Silicon (Dimethicone/Simethicone). The drug's mechanism of action is non-systemic, meaning it is not absorbed into the bloodstream, which is consistent with the absence of this type of interaction.

Q: If I miss a dose, does it affect the overall effectiveness of Silicon?

A: Official instructions state that since the product is used as needed, when a dose is remembered, the user should continue with the regimen, and it is advised to avoid doubling the next scheduled dose. Missing a dose may result in a temporary return of symptoms but does not typically impact the general pattern of use.

Q: Can I crush or split the Silicon pill?

A: Official administration instructions state that chewable tablets must be thoroughly chewed before swallowing. For softgel capsules, the official instruction is to retain the original form. Altering the form of any medication can change how it works, so the preparation steps described in the official instructions should be followed.

Q: Does Silicon affect the efficacy of birth control pills?

A: The only documented drug interaction for the oral form is a physical binding that reduces the absorption of Levothyroxine (a thyroid hormone). While no specific warning is noted for birth control pills, this non-systemic physical mechanism suggests that the absorption of any co-administered oral medicine may be potentially altered if they are taken simultaneously.

Q: Does Silicon interact with common pain relievers like ibuprofen?

A: Official labeling lists no contraindications or specific warnings for common pain relievers like ibuprofen. The primary interaction risk is restricted to the potential for physical interference with the absorption of Levothyroxine (thyroid hormone). Other common drug interactions related to metabolic enzymes are absent because Silicon is not absorbed into the body.

Q: How long does it typically take to feel the effects of Silicon?

A: Due to its physical mechanism of reducing the surface tension of gas bubbles in the gut, the onset of symptom relief for the oral form is generally understood to be rapid. Based on the physical mechanism, relief of symptoms is often reported to occur rapidly after the compound reaches the site of action.

Q: I've heard Silicon causes X side effect; how often does that happen according to studies?

A: Regulatory documents describe the adverse reactions associated with Silicon as generally mild and infrequent. The primary regulatory labeling may not include specific percentages or incidence rates for every reported side effect, which is common for Over-The-Counter products.

Q: Is Silicon safe to use if I have a history of kidney problems?

A: Official labeling states that there are no official restrictions for use in patients with a history of kidney (renal) or liver (hepatic) impairment. This is because the substance is classified as a non-systemic agent, meaning it is not absorbed into the body and is not cleared by these organs.

Q: Do official documents mention any food interactions with Silicon?

A: Official regulatory documents explicitly state that no interactions with food are documented for this medicine. The product information states it can generally be taken with or without food, as no food interactions are documented.

Q: What happens if I stop taking Silicon suddenly?

A: Because the drug is non-systemic, non-hormonal, and is not a central nervous system (CNS) active agent, official labeling does not include warnings for withdrawal or rebound symptoms upon sudden discontinuation. The physical effect simply stops once the medicine has passed through the body.

Q: Is Silicon considered a long-term or short-term treatment?

A: The oral form is generally labeled for as-needed use for the acute symptoms of gas and bloating. While there are no specific warnings against long-term use due to its non-systemic nature, continuous long-term use is not typically detailed in the standard product information.

Q: Is Silicon available over the counter in any country?

A: In the United States, the drug is officially classified as an Over-The-Counter (OTC) drug by the FDA for its uses as a skin protectant and antifoaming agent. This classification defines it as a drug that is available without a prescription.

Q: How long does Silicon stay in your system after you stop taking it?

A: Since Silicon is classified as a pharmacologically inert substance and is not significantly absorbed systemically, it does not have a measurable systemic half-life. The compound is eliminated naturally from the body via the digestive tract or through cleansing the skin.

Q: Does Silicon cause sleepiness or affect my driving ability?

A: Official regulatory documents do not list central nervous system (CNS) side effects such as sedation, drowsiness, or impairment of driving ability. This is consistent with its classification as a non-systemic agent that does not act on the brain or nerves.

Q: Is Silicon a controlled substance?

A: No, the drug is categorized as Not a controlled drug by the Drug Enforcement Administration (DEA) scheduling system. It has no potential for abuse or dependence.

Q: Do official prescribing guides mention any lifestyle changes needed with Silicon?

A: Official prescribing guides do not mandate specific lifestyle changes while using this medicine. However, patient information may note that certain practices, such as reducing gas-causing foods or using proper skin hygiene, align with the drug's uses.

Q: Is Silicon addictive?

A: No, the drug has no known potential for abuse. It is not listed as habit-forming or addictive in regulatory documents, which aligns with its non-systemic, physical mechanism of action.

Q: Does Silicon interact with grapefruit juice?

A: Official labeling explicitly states that no interactions with food or herbal products are documented. The absence of a specific interaction with grapefruit juice is consistent with the drug's non-systemic profile.

Q: Is Silicon used only for chronic conditions?

A: The oral form is primarily approved for the relief of acute symptoms of gas, bloating, and pressure, and the topical form is used for temporary skin protection. The official use for acute symptoms indicates that it is an appropriate option for as-needed use.

Q: What should I do if I get a mild rash after starting Silicon?

A: The regulatory label indicates that a severe allergic reaction can include a rash and hives. The label indicates that if signs of a severe allergic reaction occur, such as a severe rash or swelling of the face, tongue, or throat, it is an event that requires immediate medical attention.

Q: Are there specific warnings for people with mental health issues using Silicon?

A: Official labeling includes no specific warnings for people with mental health issues. This is because the substance is not systemically absorbed into the body and is not an active agent on the central nervous system (CNS).

Q: Is Silicon a relatively new medicine?

A: Silicon (Dimethicone/Simethicone) is part of an official Over-The-Counter (OTC) Monograph. This designation is granted to ingredients that have been recognized by the FDA as safe and effective for their intended use for a significant period of time.

Q: I feel better; can I reduce the amount of Silicon I take?

A: The official labeling indicates that the drug is appropriate for use as needed for symptomatic relief. The official directions provide guidance on the frequency of administration to address the question of whether a person can adjust their usage.

How should Silicon be stored and disposed of?

The storage and disposal of Dimethicone/Simethicone must strictly adhere to regulatory labeling to maintain stability and ensure safety. The product must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with protection from excessive heat, moisture, and freezing. The container must be kept tightly closed. The labeling mandates that the product be stored out of the sight and reach of children.

Disposal must follow government guidelines. Unused or expired medicine should be discarded through an authorized medicine take-back program. It is prohibited to flush the product down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Silicon found in:

A-Z Index: